Investigative Ophthalmology & Visual Science Cover Image for Volume 58, Issue 8
June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Marfan Syndrome: Biomechanics of the cornea as new noninvasive method for assessment of disease progression
Author Affiliations & Notes
  • Andreas Frings
    Department of Ophthalmology, University Hospital Düsseldorf, Heinrich-Heine University, , Düsseldorf, Germany
  • Dido Isabel Scheibenberger
    Ophthalmology, University Hospital Hamburg, Hamburg, Germany
    Med School, University of Hamburg, Hamburg, Germany
  • Johannes Steinberg
    zentrumsehstärke, Hamburg, Germany
    Ophthalmology, University Hospital Hamburg, Hamburg, Germany
  • Helke Schueler
    Cardiology, University Hospital Hamburg, Hamburg, Germany
  • Yskert von Kodolitsch
    Cardiology, University Hospital Hamburg, Hamburg, Germany
  • Vasyl Druchkiv
    Ophthalmology, University Hospital Hamburg, Hamburg, Germany
  • Toam Katz
    Ophthalmology, University Hospital Hamburg, Hamburg, Germany
  • Stephan Johannes Linke
    zentrumsehstärke, Hamburg, Germany
    Ophthalmology, University Hospital Hamburg, Hamburg, Germany
  • Footnotes
    Commercial Relationships   Andreas Frings, None; Dido Isabel Scheibenberger , None; Johannes Steinberg, None; Helke Schueler, None; Yskert von Kodolitsch, None; Vasyl Druchkiv, None; Toam Katz, None; Stephan Johannes Linke, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 4327. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Andreas Frings, Dido Isabel Scheibenberger, Johannes Steinberg, Helke Schueler, Yskert von Kodolitsch, Vasyl Druchkiv, Toam Katz, Stephan Johannes Linke; Marfan Syndrome: Biomechanics of the cornea as new noninvasive method for assessment of disease progression. Invest. Ophthalmol. Vis. Sci. 2017;58(8):4327.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate corneal air-puff deformation responses as predictor of disease status and progression in Marfan Syndrome (MFS).

Methods : This prospective observational clinical study monitored right eyes of 44 individuals (19 female, 25 male; mean age 42±12) diagnosed with MFS. The revised Ghent criteria, with particular attention being paid to the degree of aortic root dilatation (Z-Score) as correlates of disease status, were correlated with ocular biometry, corneal topography, tomography (Pentacam [Oculus]; Galilei G6 [Ziemer]) and dynamic Scheimpflug-based biomechanical analyses (CorvisST [CST; Oculus]). These findings were compared to 30 control subjects. A t-test or Wilcoxon matched-pairs test were used to test for statistically significant differences between these groups. Our study was approved by the local Ethics Committee Hamburg.

Results : Comparing control- and MFS-eyes, the corneal biomechanical parameters A1 length, A2 length, radius of the inward-bended cornea, and deflection length at the highest concavity revealed statistically significant differences (P<0.05). In addition, the comparison between low- and high-risk patients demonstrated consistently increasing differences with increasing statistical significance between mild and those with advance MFS stages.

Conclusions : In vivo noninvasive biomechanical analyses (CST) offer a new reliable method to describe and distinct
features of corneal deformation responses between low- and high-risk patients with MFS. In the future corneal air-puff deformation responses might therefore be used in early identification of critically ill patients at high risk of disease progression as an adjunct to existing diagnostic tests.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×